Izotropic Corp.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CA46604F1099
CAD
0.30
-0.02 (-4.69%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Izotropic Corp. stock-summary
stock-summary
Izotropic Corp.
Pharmaceuticals & Biotechnology
Izotropic Corporation (Izotropic) is a Canada-based company, which is engaged in commercialization of breast imaging technology for early diagnosis of breast cancer. The Company’s breast computed tomography (CT) imaging system produces breast images in three-dimensional (3D). Izotropic’s imaging system identifies tumors and determines their size, shape, location and depth. The Company makes use of cone-beam computed tomography technology to scan only the breast of interest. Izotropic’s platform computer processes raw images to reconstruct 3D images and allows radiologists to view the breast anatomy from any angle. It also offers a maximum-intensity projection (MIP) viewing capability and zoom capability on a region of interest (ROI).
Company Coordinates stock-summary
Company Details
15718 39a Ave , SURREY BC : V3Z 0L1
stock-summary
Tel: 1 604 5429458
stock-summary
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summary Board of Directorsstock-summary
Management
Designation
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
(Quarterly Results - Apr 2025)
Net Profit:
-1 Million
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

CAD 28 Million ()

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.53

stock-summary
Return on Equity

49.31%

stock-summary
Price to Book

-5.25